ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.445
-0.015 (-1.03%)
Aug 13, 2026, 5:24 PM CET
STO:EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 6.87M SEK in the quarter ending March 31, 2026, with 132.26% growth. This brings the company's revenue in the last twelve months to 16.12M, up 74.74% year-over-year. In the year 2025, ExpreS2ion Biotech Holding AB had annual revenue of 12.21M with 56.00% growth.
Revenue (ttm)
16.12M
Revenue Growth
+74.74%
P/S Ratio
2.13
Revenue / Employee
848.32K
Employees
19
Market Cap
34.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.21M | 4.38M | 56.00% |
| Dec 31, 2024 | 7.83M | -974.00K | -11.07% |
| Dec 31, 2023 | 8.80M | 2.65M | 43.07% |
| Dec 31, 2022 | 6.15M | -7.58M | -55.21% |
| Dec 31, 2021 | 13.73M | -1.53M | -10.04% |
| Dec 31, 2020 | 15.26M | 1.43M | 10.37% |
| Dec 31, 2019 | 13.83M | 4.96M | 55.94% |
| Dec 31, 2018 | 8.87M | -927.00K | -9.46% |
| Dec 31, 2017 | 9.80M | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 274.03M |
| Fluicell AB | 20.15M |
| AcouSort AB | 10.05M |
| Spago Nanomedical AB | 4.38M |
| Aptahem AB | 2.52M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| Alligator Bioscience AB | 520.00K |
ExpreS2ion Biotech Holding AB News
- 2 months ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - ExpreS2ion Biotech Holding AB Quarterly report: Q1 2026 - Filings
- 2 months ago - ExpreS2ion Biotech Holding AB Slides: Q1 2026 - Filings
- 6 months ago - ExpreS2ion Biotech Holding AB Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - ExpreS2ion Biotech Holding AB Quarterly report: Q4 2025 - Filings
- 6 months ago - ExpreS2ion Biotech Holding AB Slides: Q4 2025 - Filings
- 6 months ago - ExpreS2ion Biotech Holding AB Annual report: Q4 2025 - Filings
- 9 months ago - ExpreS2ion Biotech Holding AB Transcript: Life Science Summit 2025 - Transcripts